Preliminary efficacy and safety analysis: 12-month results in 83 patients using a novel approach of widefield radiation therapy for extensive skin field cancerization with or without keratinocyte cancers

References

• Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963–968.
   PubMed Web of Science ®Google Scholar
• Willenbrink TJ, Ruiz ES, Cornejo CM, et al. Field cancerization: definition, epidemiology, risk factors, and outcomes. J Am Acad Dermatol. 2020;83(3):709–717.
   PubMed Web of Science ®Google Scholar
• Acar A, Karaarslan I. Comparison of actinic keratosis and severity index with physician global assessment and total lesion count and the ability to predict skin cancer. Dermatol Pract Concept. 2022;12(1):e2022031.
   PubMedGoogle Scholar
• Baker C, James A, Supranowicz M, et al. Method of assessing skin cancerisation and keratoses (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerisation. Clin Exp Dermatol. 2022.DOI:10.1111/ced.15136.
   PubMed Web of Science ®Google Scholar
• Madani S, Marwaha S, Dusendang JR, et al. Ten-Year follow-up of persons with Sun-Damaged skin associated with subsequent development of cutaneous squamous cell carcinoma. JAMA Dermatol. 2021;157(5):559–565.
   PubMed Web of Science ®Google Scholar
• Dréno B, Cerio R, Dirschka T, et al. A novel actinic keratosis field assessment scale for grading actinic keratosis disease severity. Acta Derm Venereol. 2017;97(9):1108–1113.
   PubMed Web of Science ®Google Scholar
• Soyer HP, Prow TW, Jemec GBE, editors. Actinic keratosis (current problems in dermatology). Basel, Switzerland: Karger; 2014.
   Google Scholar
• Sinclair R, Baker C, Spelman L, et al. A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies. Australas J Dermatol. 2021;62(2):119–123.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer; 2020.
   Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Urban K, Mehrmal S, Uppal P, et al. The global burden of skin cancer: a longitudinal analysis from the global burden of disease study, 1990–2017. JAAD Int. 2021;2:98–108.
   PubMedGoogle Scholar
• Perera E, Gnaneswaran N, Staines C, et al. Incidence and prevalence of non-melanoma skin cancer in Australia: a systematic review. Australas J Dermatol. 2015;56(4):258–267.
   PubMed Web of Science ®Google Scholar
• AIHW. Australian cancer incidence and mortality (ACIM) books: non-melanoma skin cancer, all types. Canberra (Australia): Australian Institute of Health and Welfare; 2014. Available from: www.aihw.gov.au/acim-books
   Google Scholar
• Anselmo Lima C, Sampaio Lima M, Maria Da Silva A, et al. Do cancer registries play a role in determining the incidence of non-melanoma skin cancers? Eur J Dermatol. 2018;28(2):169–176.
   PubMed Web of Science ®Google Scholar
• Czarnecki D, Sutton T, Czarnecki C, et al. A 10-year prospective study of patients with skin cancer. J Cutan Med. Surg. 2002;6(5):427–429.
   PubMed Web of Science ®Google Scholar
• Wehner MR, Linos E, Parvataneni R, et al. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma. JAMA Dermatol. 2015;151(4):382–388.
   PubMed Web of Science ®Google Scholar
• Cancer Council Australia Keratinocyte Cancers Guideline Working Party. Clinical practice guidelines for keratinocyte cancer. [cited 2021 Apr 8]. Sydney (Australia): Cancer Council Australia; 2019. Available from: https://wiki.cancer.org.au/australia/Guidelines:Keratinocyte_carcinoma. Af, editor. [Version URL: https://wiki.cancer.org.au/australiawiki/index.php?oldid=213931
   Google Scholar
• Stuart SE, Schoen P, Jin C, et al. Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using appropriate use criteria. J Am Acad Dermatol. 2017;76(6):1131.e1–1138.e1.
   Web of Science ®Google Scholar
• Cho M, Gordon L, Rembielak A, et al. Utility of radiotherapy for treatment of basal cell carcinoma: a review. Br J Dermatol. 2014;171(5):968–973.
   PubMed Web of Science ®Google Scholar
• Likhacheva A, Awan M, Barker CA, et al. Definitive and postoperative radiation therapy for basal and squamous cell cancers of the skin: executive summary of an American society for radiation oncology clinical practice guideline. Pract Radiat Oncol. 2020;10(1):8–20.
   PubMed Web of Science ®Google Scholar
• Potter A, Price M, Papworth D, et al. A technique for treating extended skin field cancerisation using volumetric modulated arc therapy. Int J Radiol Radiat Ther. 2019;6(4):111–119.
   Google Scholar
• Wong B, Christie D, Hellyer J, et al. Volumetric modulated arc therapy (VMAT) for extensive skin field cancerisation (ESFC) – exploring the limits of treatment volumes with a case series of backs. IJRRT. 2020;7(6):184–192.
   Google Scholar
• Santos ED, Green JA, Bhandari N, et al. Tangential volumetric modulated radiotherapy – a new technique for large scalp lesions with a case study in lentigo maligna. Int J Bioautomation. 2015;19(2):223–236.
   Google Scholar
• Lozano F, Perez N, Iglesias A, et al. Volumetric arc therapy for total scalp irradiation: case report for a recurrent basal cell carcinoma of the scalp. Ecancermedicalscience. 2017;11:737–737.
   PubMed Web of Science ®Google Scholar
• Nicolini G, Abraham S, Fogliata A, et al. Critical appraisal of volumetric-modulated arc therapy compared with electrons for the radiotherapy of cutaneous Kaposi's sarcoma of lower extremities with bone sparing. Br J Radiol. 2013;86(1023):20120543.
   PubMed Web of Science ®Google Scholar
• WHO handbook for reporting results of cancer treatment. 1979.
   Google Scholar
• Jansen MHE, Kessels J, Nelemans PJ, et al. Randomized trial of four treatment approaches for actinic keratosis. N Engl J Med. 2019;380(10):935–946.
   PubMed Web of Science ®Google Scholar
• Pomerantz H, Hogan D, Eilers D, et al. Long-term efficacy of topical fluorouracil cream, 5%, for treating actinic keratosis: a randomized clinical trial. JAMA Dermatol. 2015;151(9):952–960.
   PubMed Web of Science ®Google Scholar
• Institute NC. Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 Available from: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm#ctc_50. 2017
   Google Scholar
• Lovett RD, Perez CA, Shapiro SJ, et al. External irradiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys. 1990;19(2):235–242.
   PubMedGoogle Scholar
• Dréno B, Amici JM, Basset-Seguin N, et al. Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians. J Eur Acad Dermatol Venereol. 2014;28(9):1141–1149.
   PubMed Web of Science ®Google Scholar
• Salasche SJ, Levine N, Morrison L. Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: an open-label trial. J Am Acad Dermatol. 2002;47(4):571–577.
   PubMed Web of Science ®Google Scholar